Shanghai Unicar-therapy Bio-medicine Technology Co.,ltd

This early-stage trial tests a new treatment called U01 (ssCART-19) for people with B-cell lymphoma that has come back or not responded to other treatments. The therapy uses specially engineered immune cells to target and kill cancer cells. The study will check if the treatment i…

This early-stage study is testing a new treatment called CD30-targeted CAR-T cells for people with a type of lymphoma that has returned or not responded to standard therapy. The treatment involves taking a patient's own immune cells, modifying them to recognize and attack cancer …